Ghodssi-Ghassemabadi Robabeh, Hajizadeh Ebrahim, Kamian Shaghayegh, Mahmoudi Mahmood
Department of Biostatistics, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Shahid Beheshti University of Medical Sciences, Imam Hossein Hospital, Tehran, Iran.
J Egypt Natl Canc Inst. 2019 Nov 29;31(1):6. doi: 10.1186/s43046-019-0006-z.
Colorectal cancer (CRC) is a disease of old age, but its incidence has been rising among younger population compared to older ones. Nevertheless, there is a controversy over survival of younger patients compared to the older ones. Therefore, in the current study, we investigated the clinicopathological features and survival of the younger (< 50 years) versus older (≥ 50 years) CRC patients.
The younger and older groups consisted of 39.4% and 60.6% of patients, respectively. Both age groups were comparable regarding the symptom presentation and duration, and pre-operative carcinoembryonic antigen (CEA). The younger patients were diagnosed with a higher proportion of poorly differentiated (14.7% vs. 8.3%; p < 0.001) and more advanced tumors (53.2% vs. 45.9%; p = 0.266). The rectum tumor site was significantly more common among the younger patients (p = 0.021). The overall survival (OS) (p = 0.278), the cancer-specific survival (CSS) (p = 0.233), and the disease-free survival (DFS) (p = 0.497) did not differ significantly between the two groups. Based on Cox regression model, elevated pre-operative CEA level (HR = 1.41; 95%CI of 1.01-1.97), advanced tumor stage (6.06; 95%CI of 3.03-12.15), and poorly differentiated tumor (HR = 1.69; 95%CI of 1.05-2.71) were associated with decreased survival.
The younger patients did not have poor prognosis compared to the older ones despite having an advanced tumor stage and a poor tumor differentiation.
结直肠癌(CRC)是一种老年疾病,但与老年人群相比,其在年轻人群中的发病率一直在上升。然而,与老年患者相比,年轻患者的生存率存在争议。因此,在本研究中,我们调查了年轻(<50岁)与老年(≥50岁)CRC患者的临床病理特征和生存率。
年轻组和老年组分别占患者的39.4%和60.6%。两组在症状表现、持续时间和术前癌胚抗原(CEA)方面具有可比性。年轻患者中低分化肿瘤(14.7%对8.3%;p<0.001)和更晚期肿瘤(53.2%对45.9%;p=0.266)的诊断比例更高。直肠肿瘤部位在年轻患者中明显更常见(p=0.021)。两组之间的总生存期(OS)(p=0.278)、癌症特异性生存期(CSS)(p=0.233)和无病生存期(DFS)(p=0.497)差异均无统计学意义。基于Cox回归模型,术前CEA水平升高(HR=1.41;95%CI为1.01-1.97)、肿瘤晚期(HR=6.06;95%CI为3.03-12.15)和低分化肿瘤(HR=1.69;95%CI为1.05-2.71)与生存率降低相关。
尽管年轻患者肿瘤分期较晚且肿瘤分化较差,但与老年患者相比,其预后并不差。